Ocugen (OCGN) Enterprise Value Growth (1y) (2015 - 2025)
Ocugen (OCGN) Enterprise Value Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -43.32% |
| Jun 30, 2024 | 77.76% |
| Mar 31, 2024 | 65.62% |
| Dec 31, 2023 | 56.60% |
| Sep 30, 2023 | 47.37% |
| Jun 30, 2023 | 38.63% |
| Mar 31, 2023 | 40.88% |
| Dec 31, 2022 | 4.24% |
| Sep 30, 2022 | 9.56% |
| Jun 30, 2022 | 4.66% |
| Mar 31, 2022 | -160.69% |
| Dec 31, 2021 | -295.02% |
| Sep 30, 2021 | -487.97% |
| Jun 30, 2021 | -705.92% |
| Mar 31, 2021 | -1,459.04% |
| Dec 31, 2020 | -222.93% |
| Sep 30, 2020 | -24.87% |
| Jun 30, 2020 | -2,106.07% |
| Mar 31, 2020 | -934.28% |
| Dec 31, 2019 | -357.21% |